Skip to content
Search for:
Solutions
Therapeutic Intelligence & Biomarker Discovery
Genialis™ krasID
Genialis™ Expressions
Approach
Genialis™ Supermodel
Genialis ResponderID™
Why RNA?
Case Studies
About Us
Meet Our Team
Careers
Compliance
Media
News and Events
Scientific Publications
Press Releases
TPM Podcast
Get in Touch
Solutions
Therapeutic Intelligence & Biomarker Discovery
Genialis™ krasID
Genialis™ Expressions
Approach
Genialis™ Supermodel
Genialis ResponderID™
Why RNA?
Case Studies
About Us
Meet Our Team
Careers
Compliance
Media
News and Events
Scientific Publications
Press Releases
TPM Podcast
Get in Touch
Search for:
White papers and other resources
Scientific journals
Conference posters
November 30, 2022
SITC 2022
Xerna tumor microenvironment subtypes as a biomarker in lung cancer patients
September 30, 2022
ESMO 2022
Predicting benefit from maintenance durvalumab after first-line chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA assay
April 11, 2022
AACR 2022
Xerna™ TME Panel: A pan-cancer RNA-based investigational assay designed to predict patient response to angiogenic- and immune-targeted therapies
April 12, 2021
AACR 2021
RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer
November 10, 2020
SITC 2020
Development of an RNA-based Diagnostic Platform Based on the Tumor Microenvironment Dominant Biology
Previous
1
2
3
Load More Posts
Page load link
